Report Examines Funding, R&D, Challenges Of Developing, Deploying Vaccines For Emerging Infectious Diseases

GlobalData: Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies
“Emerging infectious diseases (EIDs) are characterized by unpredictable incidence and clinical patterns that pose unique challenges for vaccine development. As outbreaks of Ebola virus, Zika virus, and other EIDs have occurred in the past decade, drug developers and global health organizations are turning to novel funding and clinical trial paradigms to improve epidemic preparedness. This report covers current and future challenges for the development and deployment of vaccines for EIDs, focusing on vaccine platform technology and research, funding mechanisms, and collaborative global partnerships…” (December 2018).